RVMD
177.96-11.30 -5.97%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- RVMD
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $40.84B
- Employees
- 883
- Currency
- USD
- Website
- https://www.revmed.com
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and…
Latest coverage
Related Other stocks
UnitedHealth Group IncorporatedUNH
J.B. Hunt Transport Services, Inc.JBHT
Zillow Group, Inc.ZG
Opendoor Technologies Inc.OPEN